Oct 16, 2026 08:00AM
Oct 16, 2026 08:00AM
Aug 13, 2026 08:01AM
Aug 13, 2026 08:00AM
Jul 30, 2026 08:02AM
Jul 30, 2026 08:00AM
Jul 22, 2026 07:01AM Curis reports updated emavusertib trial data in PCNSL and CLL
Jul 22, 2026 07:00AM
Jul 6, 2026 09:30AM
Jun 26, 2026 09:43AM
Jun 26, 2026 09:42AM
May 12, 2026 04:00PM
May 12, 2026 04:00PM
May 5, 2026 05:11PM Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026
Mar 19, 2026 04:01PM
Mar 19, 2026 04:00PM
Mar 12, 2026 04:27PM
Jan 9, 2026 08:00AM
Jan 9, 2026 08:00AM
Jan 7, 2026 08:45AM
Jan 7, 2026 08:45AM Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
Dec 9, 2025 08:00AM
Nov 14, 2025 09:26AM
Nov 6, 2025 04:00PM
Nov 6, 2025 04:00PM
Oct 30, 2025 04:00PM
Oct 3, 2025 04:00PM
Sep 2, 2025 10:43AM Curis to Present at Upcoming Healthcare Conferences in September
Aug 5, 2025 08:02AM
Aug 5, 2025 08:00AM
Jul 29, 2025 08:30AM
Jul 2, 2025 08:33AM
Jul 2, 2025 08:32AM
May 6, 2025 06:16PM
May 6, 2025 08:00AM Curis Provides First Quarter 2025 Business Update
Apr 29, 2025 08:00AM
Apr 2, 2025 04:05PM
Apr 1, 2025 06:47AM
Mar 31, 2025 08:01AM
Mar 31, 2025 08:00AM
Mar 28, 2025 04:07PM
Dec 10, 2024 08:13AM Curis (CRIS) Announces Additional Data from TakeAim Leukemia Study
Dec 10, 2024 08:00AM
Nov 14, 2024 08:01AM
Nov 14, 2024 08:00AM
Nov 7, 2024 08:00AM
Oct 29, 2024 06:06AM
Oct 29, 2024 06:04AM
Sep 27, 2024 01:59PM Laidlaw Reiterates Buy Rating on Curis (CRIS)
Sep 23, 2024 08:30AM

335,228 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All